{"DataElement":{"publicId":"3194001","version":"1","preferredName":"New Sarcoma Cellular Differentiation Category","preferredDefinition":"New; having no previous example or precedent or parallel._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._A usually aggressive malignant mesenchymal cell tumor most commonly arising from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels.  Sarcomas occur in both children and adults.  The prognosis depends largely on the degree of differentiation (grade) of the tumor.  Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma. -- 2004_In cancer, refers to how mature (developed) the cancer cells are in a tumor. Differentiated tumor cells resemble normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells, which lack the structure and function of normal cells and grow uncontrollably._Category; used informally to mean a class of things.","longName":"3193998v1.0:3194000v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3193998","version":"1","preferredName":"New Neoplasm Cellular Differentiation","preferredDefinition":"New; having no previous example or precedent or parallel._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._In cancer, refers to how mature (developed) the cancer cells are in a tumor. Differentiated tumor cells resemble normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells, which lack the structure and function of normal cells and grow uncontrollably.","longName":"3108264v1.0:2200802v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3108264","version":"1","preferredName":"New Neoplasm","preferredDefinition":"New; having no previous example or precedent or parallel.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C25586:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"New","conceptCode":"C25586","definition":"Having no previous example or precedent or parallel; of a kind not seen before.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8883C12C-4F39-5E58-E040-BB89AD437DB2","latestVersionIndicator":"Yes","beginDate":"2010-06-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-08","modifiedBy":"ONEDATA","dateModified":"2010-06-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2200802","version":"1","preferredName":"Differentiation","preferredDefinition":"In cancer, refers to how mature (developed) the cancer cells are in a tumor. Differentiated tumor cells resemble normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells, which lack the structure and function of normal cells and grow uncontrollably.","longName":"C18314","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cellular Differentiation","conceptCode":"C18314","definition":"In cancer, refers to how mature (developed) the cancer cells are in a tumor. Differentiated tumor cells resemble normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells, which lack the structure and function of normal cells and grow uncontrollably.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F169098A-EBC6-306E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-08","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D6CD5C2-5464-12C9-E040-BB89AD43651A","latestVersionIndicator":"Yes","beginDate":"2011-03-01","endDate":null,"createdBy":"WHITES","dateCreated":"2011-03-01","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg 2/2011 (sw)","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3194000","version":"1","preferredName":"Sarcoma Cellular Differentiation Category","preferredDefinition":"A usually aggressive malignant mesenchymal cell tumor most commonly arising from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels.  Sarcomas occur in both children and adults.  The prognosis depends largely on the degree of differentiation (grade) of the tumor.  Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma. -- 2004_In cancer, refers to how mature (developed) the cancer cells are in a tumor. Differentiated tumor cells resemble normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells, which lack the structure and function of normal cells and grow uncontrollably._Category; used informally to mean a class of things.","longName":"3194000v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"De-Differentiated","valueDescription":"Dedifferentiated Liposarcoma","ValueMeaning":{"publicId":"3162600","version":"1","preferredName":"Dedifferentiated Liposarcoma","longName":"3162600","preferredDefinition":"A liposarcoma of any histologic subtype mixed with a non-lipomatous, high grade sarcomatous component.  The non-lipomatous component may be present in the primary lesion or at the site of metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dedifferentiated Liposarcoma","conceptCode":"C3704","definition":"An atypical lipomatous tumor/well differentiated liposarcoma that shows progression to a usually non-lipomatous, high grade sarcoma.  The non-lipomatous sarcoma component may be present in the primary lesion or at the site of recurrence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"95BA0EB9-C6DD-0EB8-E040-BB89AD437157","latestVersionIndicator":"Yes","beginDate":"2010-11-23","endDate":null,"createdBy":"WHITES","dateCreated":"2010-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9D6CD5C2-54AC-12C9-E040-BB89AD43651A","beginDate":"2011-03-01","endDate":null,"createdBy":"WHITES","dateCreated":"2011-03-01","modifiedBy":"ONEDATA","dateModified":"2011-03-01","deletedIndicator":"No"},{"value":"Well-Differentiated","valueDescription":"Well Differentiated Liposarcoma","ValueMeaning":{"publicId":"3179373","version":"1","preferredName":"Well Differentiated Liposarcoma","longName":"3179373","preferredDefinition":"A locally aggressive malignant neoplasm composed of mature adipocytes showing cell size variation and nuclear atypia.  It is often associated with the presence of hyperchromatic multinucleated stromal cells, and varying numbers of lipoblasts. There are three histologic subtypes, sclerosing, inflammatory, and spindle cell liposarcoma.  These tumors do not usually metastasize unless they undergo dedifferentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Well Differentiated Liposarcoma","conceptCode":"C4250","definition":"A locally aggressive malignant neoplasm composed of mature adipocytes showing cell size variation and nuclear atypia.  It is often associated with the presence of hyperchromatic multinucleated stromal cells, and varying numbers of lipoblasts. There are three histologic subtypes, sclerosing, inflammatory, and spindle cell liposarcoma.  These tumors do not usually metastasize unless they undergo dedifferentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-87F1-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"ONEDATA","dateModified":"2010-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9D6CD5C2-54C0-12C9-E040-BB89AD43651A","beginDate":"2011-03-01","endDate":null,"createdBy":"WHITES","dateCreated":"2011-03-01","modifiedBy":"ONEDATA","dateModified":"2011-03-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3193999","version":"1","preferredName":"Sarcoma Cellular Differentiation Category","preferredDefinition":"A usually aggressive malignant mesenchymal cell tumor most commonly arising from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels.  Sarcomas occur in both children and adults.  The prognosis depends largely on the degree of differentiation (grade) of the tumor.  Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma. -- 2004:In cancer, refers to how mature (developed) the cancer cells are in a tumor. Differentiated tumor cells resemble normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells, which lack the structure and function of normal cells and grow uncontrollably.:Category; used informally to mean a class of things.","longName":"C9118:C18314:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sarcoma","conceptCode":"C9118","definition":"A usually aggressive malignant neoplasm of the soft tissue or bone. It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Cellular Differentiation","conceptCode":"C18314","definition":"In cancer, refers to how mature (developed) the cancer cells are in a tumor. Differentiated tumor cells resemble normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells, which lack the structure and function of normal cells and grow uncontrollably.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D6CD5C2-547A-12C9-E040-BB89AD43651A","latestVersionIndicator":"Yes","beginDate":"2011-03-01","endDate":null,"createdBy":"WHITES","dateCreated":"2011-03-01","modifiedBy":"ONEDATA","dateModified":"2011-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D6CD5C2-548B-12C9-E040-BB89AD43651A","latestVersionIndicator":"Yes","beginDate":"2011-03-01","endDate":null,"createdBy":"WHITES","dateCreated":"2011-03-01","modifiedBy":"WHITES","dateModified":"2011-03-01","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg 2/2011","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3787498","version":"1","longName":"TCGA 2.6 by Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3787518","version":"1","longName":"SARC","context":"NCIP"}]}],"AlternateNames":[{"name":"new_tumor_cellular_differentiation","type":"TCGA_XML_Name","context":"NCIP"}],"ReferenceDocuments":[{"name":"Is the New Tumor Well-Differe","type":"Preferred Question Text","description":"Is the New Tumor Well-Differentiated or De-Differentiated?","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D6CD5C2-54CA-12C9-E040-BB89AD43651A","latestVersionIndicator":"Yes","beginDate":"2011-03-01","endDate":null,"createdBy":"WHITES","dateCreated":"2011-03-01","modifiedBy":"TSESU","dateModified":"2018-07-13","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg 1/2011 (sw)","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}